Brooke Ringel is a senior associate in the firm’s Washington, D.C. office. Her practice focuses on international trade, assisting companies and associations across a wide range of industries navigate and utilize U.S. and foreign trade laws and policies.
Brooke has experience representing domestic industry in international trade remedies litigation against unfairly priced and subsidized foreign imports, particularly with respect to five-year “sunset” reviews before the U.S. International Trade Commission (ITC). She also advises clients on export control, sanctions, and anti-corruption compliance matters. In the compliance area, Brooke has extensive experience assisting clients in conducting global trade compliance audits, investigations, and due diligence reviews.
Prior to joining Kelley Drye, Brooke served as Associate Vice President at the Pharmaceutical Research and Manufacturers of America (PhRMA), where she led the association’s work on global intellectual property advocacy and supported trade policy issues. Her work included advocating on behalf of the innovative biopharmaceutical industry with the U.S. and foreign governments, developing and executing strategic solutions to international intellectual property and trade challenges, building alliances with other stakeholders to achieve common objectives, and supporting the association’s members in their international policy engagement efforts. Brooke also served as a Special Assistant Attorney General for the District of Columbia, litigating a wide range of civil matters on behalf of the District, before joining Kelley Drye.